Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ramdev Chemicals is a leading Indian manufacturer of Active Pharmaceutical Ingredients (APIs) and advanced intermediates, specializing in complex chemistry and niche therapeutic areas. The company provides contract development and manufacturing services (CDMO) to global pharmaceutical firms, focusing on segments such as the central nervous system, cardiovascular health, and gastrointestinal treatments. Headquartered in Boisar, Maharashtra, its manufacturing facilities are compliant with international standards, including the US FDA. In 2019, Ramdev Chemicals was acquired by Advent International and integrated into the Cohance Lifesciences platform. The company is recognized for its expertise in process chemistry and its ability to scale production from laboratory to commercial volumes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ramdev Chemicals.